CXCL10 and tuberculosis: Similar to other findings, that identified elevated concentrations of soluble IP-10 in plasma, serum or urine from PTB patients [72,73,74], this study found a declining tendency of IP-10 levels in patients that turned culture negative after anti-TB drug therapy compared to the levels at the time of initiation of treatment.